Aravive Stock Cash And Equivalents
| ARAVDelisted Stock | USD 1.49 0.21 12.35% |
Aravive fundamentals help investors to digest information that contributes to Aravive's financial success or failures. It also enables traders to predict the movement of Aravive Stock. The fundamental analysis module provides a way to measure Aravive's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aravive stock.
Aravive |
Aravive Company Cash And Equivalents Analysis
Aravive's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Aravive Cash And Equivalents | 46.83 M |
Most of Aravive's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Aravive is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Aravive has 46.83 M in Cash And Equivalents. This is 94.3% lower than that of the Biotechnology sector and 89.53% lower than that of the Health Care industry. The cash and equivalents for all United States stocks is 98.27% higher than that of the company.
Aravive Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Aravive's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Aravive could also be used in its relative valuation, which is a method of valuing Aravive by comparing valuation metrics of similar companies.Aravive is currently under evaluation in cash and equivalents category among its peers.
Aravive Fundamentals
| Return On Equity | -4.76 | |||
| Return On Asset | -1.34 | |||
| Operating Margin | (3.23) % | |||
| Current Valuation | (3.16 M) | |||
| Shares Outstanding | 73.56 M | |||
| Shares Owned By Insiders | 38.68 % | |||
| Shares Owned By Institutions | 8.20 % | |||
| Number Of Shares Shorted | 1.33 M | |||
| Price To Earning | 3.34 X | |||
| Price To Book | 1.73 X | |||
| Price To Sales | 0.42 X | |||
| Revenue | 6.99 M | |||
| Gross Profit | (57.8 M) | |||
| EBITDA | (58.4 M) | |||
| Net Income | (39.85 M) | |||
| Cash And Equivalents | 46.83 M | |||
| Cash Per Share | 1.53 X | |||
| Total Debt | 6.27 M | |||
| Debt To Equity | 0.17 % | |||
| Current Ratio | 2.39 X | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (59.45 M) | |||
| Short Ratio | 0.91 X | |||
| Earnings Per Share | (0.76) X | |||
| Target Price | 0.25 | |||
| Number Of Employees | 23 | |||
| Beta | 2.19 | |||
| Market Capitalization | 2.95 M | |||
| Total Asset | 62.15 M | |||
| Retained Earnings | (616.13 M) | |||
| Working Capital | 35.86 M | |||
| Current Asset | 60.74 M | |||
| Current Liabilities | 11.48 M | |||
| Z Score | -15.89 | |||
| Net Asset | 62.15 M |
About Aravive Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aravive's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aravive using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aravive based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Aravive Stock
If you are still planning to invest in Aravive check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aravive's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |